[Federal Register Volume 69, Number 159 (Friday, October 8, 2004)]
[Notices]
[Pages 60408-60409]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-22661]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institutes of Diabetes and Digestive and Kidney 
Diseases; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Special Emphasis Panel, Clinical Trial Type 2 
Diabetes.
    Date: November 4, 2004.
    Time: 3:30 p.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6707 Democracy Blvd., 
Bethesda, MD 20814 (Telephone Conference Call).
    Contact Person: Maxine A. Lesniak, MPH, Scientific Review 
Administrator, Review Branch, DEA, NIDDK, National Institutes of 
Health, Room 756, 6707 Democracy Boulevard, Bethesda, MD 20892-5452, 
(301) 594-7792, [email protected].

(Catalogue of Federal Domestic Assistance Program No. 93.847, 
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive 
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology 
and Hematology Research, National Institutes of Health, HHS)


[[Page 60409]]


    Dated: September 30, 2004.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 04-22661 Filed 10-7-04; 8:45 am]
BILLING CODE 4140-01-M